Said Cancer. Million Fraud: A Cautionary Tale for Donors
A viral online persona hid a troubling reality: a calculated scheme built on a bogus cancer crisis. Learn the red fla...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,764 articlesA viral online persona hid a troubling reality: a calculated scheme built on a bogus cancer crisis. Learn the red fla...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Bitcoin surged to a two-week high near $64,000, signaling renewed optimism after a volatile stretch. Analysts warn th...
XRP is testing a critical price level in 2026 as regulatory clarity improves and ETF access expands. Analysts debate ...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
Pi Network launches two major Pi App Studio updates to boost persistence and AI-driven planning, even as PI token hit...
As 2026 unfolds, retirees weigh early access to Social Security against lifetime income. Early claiming can reduce mo...
A bold claim from a veteran tech analyst puts SpaceX at the center of an AI-enabled future. This guide breaks down wh...
As AI bills climb, more firms are turning to cheaper open-source AI models to manage budgets. The trend signals a shi...
As earnings season unfolds, Apogee faces a meaningful year ahead. This article breaks down Q1 signals, outlines a rea...
Oil markets swung dramatically in the first half, with prices surging and then cooling. This guide explains what that...